Patient#	Sample#	GDP:(G13/GDP/Gbeta gamma, active),(GTP, active),(Gi family/GDP/G beta/gamma, active),(RAC1-CDC42/GDP, active),(RALB/GDP, active),(RAP1B/GDP, active),(RAP2A-B/GDP, active),(RhoA-B-C/GDP, active),	GNB1/GNG2:(G13/GDP/Gbeta gamma, active),(GTP, active),(Gi family/GDP/G beta/gamma, active),	IP3:(PI-4-5-P2, active),	ADRBK1:(ADRBK1, protein),	ARR3:(ARR3, protein),	ARRB2:(ARRB2, protein),	CRK:(CRK, protein),	CXCL12:(CXCL12, protein),	Ca2+:(IP3, active),	FAK:(FAK, protein),	GNB2L1:(GNB2L1, protein),	GRK6:(GRK6, protein),	ITCH:(ITCH, protein),	JAK2:(JAK2, protein),	PDPK1:(PDPK1, protein),	PLC beta:(GNB1/GNG2, active),(PLC beta, protein),(T-Lymphocyte, active),	PTK2B:(PTK2B, protein),	PTPRC:(PTPRC, protein),	PXN:(PXN, protein),	RGS1:(RGS1, protein),	SHIP:(SHIP, protein),	SHP1-2:(SHP1-2, protein),	STAT1-3-5:(STAT1-3-5, protein),	Src Family Kinase:(Src Family Kinase, protein),	Src Family Kinases-active:(Src Family Kinases-active, protein),	UBQLN1:(UBQLN1, protein),	VAV1:(VAV1, protein),	VPS4:(VPS4, protein),	p130 Cas:(p130 Cas, protein),	CXCR4:(CXCR4, protein),	DAG:(PI-4-5-P2, active),(PLC beta, active),	G beta/gamma/PLIC-1:(GNB1/GNG2, active),(UBQLN1, active),	G beta/gamma/RACK1:(GNB1/GNG2, active),(GNB2L1, active),	HGS:(HGS, protein),(ITCH, active),(VPS4, active),	SDF1/CXCR4 (dimer):(CXCL12, active),(CXCR4 (dimer), active),	Src Family Kinase-active:(GNB1/GNG2, active),(Gi family/GTP/RGS1, active),(Src Family Kinase, active),(Src Family Kinase-active, protein),	AKT1	BAD:(AKT1, active),(BAD, protein),	FOXO1:(AKT1, active),(FOXO1, protein),	CFL1	actin filament depolymerization:(CFL1, active),	FAK/p130 Cas/Paxillin	RAP1B/GTP:(FAK/p130 Cas/Paxillin, active),(GTP, active),(Pro-B-Lymphocyte, active),(RAP1B/GDP, active),	PYK2/Paxillin/CRK:(CRK, active),(PTK2B, active),(PXN, active),(RAP1B/GTP, active),	G13/GTP	RhoA-B-C/GTP:(G13/GTP, active),(GTP, active),(RhoA-B-C/GDP, active),	Gi family/GTP	cAMP biosynthetic process:(Gi family/GTP, active),	LCK	TCR/CD3/MHC II/CD4/LCK:(GNB1/GNG2, active),(Gi family/GTP/RGS1, active),(LCK, active),(TCR/CD3/MHC II/CD4, active),	LIMK1	positive regulation of lamellipodium assembly:(LIMK1, active),	MMP9_107-707:(MMP9_107-707, protein),	PAK1	PI-3-4-5-P3	PI-3-4-P2:(PI-3-4-5-P3, active),(SHIP, active),	PI3K Class I family	PRKCZ:(PI3K Class I family, active),(PRKCZ, protein),	cell proliferation:(Hematopoietic Stem Cell, active),(PRKCZ, active),	regulation of heterotypic cell-cell adhesion:(Hematopoietic Stem Cell, active),(Integrin beta 1-Integrin alpha, active),(PRKCZ, active),(Pro-B-Lymphocyte, active),(RGS1, active),	RAC1-CDC42/GTP	cell adhesion:(FAK/p130 Cas/Paxillin, active),(Integrin beta 1-Integrin alpha, active),(Pro-B-Lymphocyte, active),(RAC1-CDC42/GTP, active),(T-Lymphocyte, active),(alpha4/beta1 Integrin, active),	RALB/GTP	RAP2A-B/GTP	SDF1/CXCR4	SDF1/CXCR4/CD45:(PTPRC, active),(SDF1/CXCR4, active),	SDF1/CXCR4/JAK2:(JAK2, active),(SDF1/CXCR4, active),	SDF1/CXCR4/SHP1-2:(GNB1/GNG2, active),(SDF1/CXCR4, active),(SHP1-2, active),	SDF1/CXCR4/VAV1:(SDF1/CXCR4, active),(VAV1, active),	SSH1:(SDF1/CXCR4, active),(SSH1, protein),	degradation:(SDF1/CXCR4, active),(VPS4, active),	receptor internalization:(G beta/gamma/PLIC-1, active),(SDF1/CXCR4, active),(T cell receptor signaling pathway, active),	STAT1-3-5-active:(SDF1/CXCR4/JAK2, active),(STAT1-3-5, active),(STAT1-3-5-active, protein),	STAT2:(SDF1/CXCR4/JAK2, active),(STAT2, protein),	chemotaxis:(AKT1, active),(CFL1, active),(Ca2+, active),(LCK, active),(LIMK1, active),(PRKCZ, active),(PYK2/Paxillin/CRK, active),(Pro-B-Lymphocyte, active),(RALB/GTP, active),(RAP2A-B/GTP, active),(RGS1, active),(RhoA-B-C/GTP, active),(SDF1/CXCR4 (dimer), active),(SDF1/CXCR4/SHP1-2, active),(SSH1, active),	establishment of cell polarity:(PI3K Class I family, active),(RAC1-CDC42/GTP, active),(SSH1, active),	STAT1-3-5 (dimer):(STAT1-3-5-active, active),	STAT2 (dimer):(STAT2, active),	
